BMS Secures Better HTA Result In Germany With Additional Data for Camzyos

 
• By Francesca Bruce
  
Germany Heart
BMS' cardiomyopathy drug Camzyos gets upgraded benefit assessment rating in Germany • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography